XML 66 R41.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Payments - Inducement Awards Outside of the 2019 Inducement Plan (Details) - Inducement Awards Outside of the 2019 Inducement Plan - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Jul. 25, 2018
Sep. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Share-Based Payments        
Share-based compensation expense   $ 0.3 $ 0.5 $ 0.1
Additional disclosures        
Weighted-average remaining contractual life     8 years 9 months 18 days  
Total unrecognized compensation related to unvested options   $ 1.2 $ 1.2  
Recognition period     1 year 6 months  
Non-statutory option        
Share-Based Payments        
Vesting period 4 years      
Options exercise price (in dollars per share) $ 3.53 $ 2.05 $ 2.05  
Exercise period 10 years      
Non-statutory option | Chief Executive Officer        
Share-Based Payments        
Options granted during the period 850,000      
Non-statutory option | Vesting period, year one        
Share-Based Payments        
Percentage that vests during the period 25.00%      
Non-statutory option | Vesting period, years 2-4        
Share-Based Payments        
Percentage that vests during the period 75.00%      
Monthly vesting period 36 months      
Non-statutory option | Upon receipt of FDA approval        
Share-Based Payments        
Percentage that vests during the period 50.00%      
Non-statutory option | First anniversary of FDA approval        
Share-Based Payments        
Percentage that vests during the period 50.00%      
Restricted Stock Units ("RSUs")        
Share-Based Payments        
Options exercise price (in dollars per share)   $ 3.53 $ 3.53  
Restricted Stock Units ("RSUs") | Chief Executive Officer        
Share-Based Payments        
Options granted during the period 150,000